MedPath
NMPA Approval

Drospirenone and Ethinylestradiol Tablets

国药准字H20249620

December 1, 2024

Drug Information

屈螺酮炔雌醇片

片剂

每片含炔雌醇0.03mg和屈螺酮3mg

化学药品

December 1, 2024

Company Information

Applicant Company

江苏省南通市经济技术开发区综合保税区广兴路1号

Manufacturing Company

江苏省南通市经济技术开发区综合保税区广兴路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

屈螺酮炔雌醇片 - NMPA 批准文号 | MedPath